Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.contractpharma.com/contents/view_breaking-news/2023-03-09/cyxone-streamlines-manufacturing-process-for-rabeximod/?widget=listSection
https://ipohub.io/companies/cyxone-ab/news/nomination-committee-appointed-for-cyxone-annual-general-meeting-2023-081120221235
https://news.cision.com/cyxone/r/cyxone-will-leverage-ind-and-use-fda-pre-review-for-covid-19-phase-2-trial,c3421070
https://news.cision.com/cyxone/r/cyxone-and-medical-university-of-vienna-announce-collaboration-to-study-broader-t20k-use-in-ms,c3377799
https://news.cision.com/cyxone/r/cyxone-initiates-feasibility-preclinical-studies-to-optimize-path-forward-for-multiple-sclerosis-dru,c3342352#:~:text=Swedish-,Cyxone%20Initiates%20Feasibility%20Preclinical%20Studies%20to%20Optimize%20Path,Multiple%20Sclerosis%20Drug%20Candidate%20T20K&text=Cyxone%20announced%20today%20the%20initiation,Sclerosis%20drug%20candidate%20T20K%20forward.
https://www.prnewswire.com/news-releases/cyxone-reports-first-covid-19-patient-screened-in-phase-2-clinical-trial-of-rabeximod-301209286.html#:~:text=STOCKHOLM%2C%20Jan.%2015%2C%202021,of%20Rabeximod%20in%20Covid%2D19.
https://www.prnewswire.com/news-releases/cyxone-has-filed-an-ind-in-the-us-with-rabeximod-following-positive-feed-back-from-pre-ind-meeting-with-the-fda-301192673.html
https://www.clinicaltrialsarena.com/news/cyxone-trial-oral-drug/
https://www.prnewswire.com/news-releases/cyxone-receives-regulatory-approval-to-initiate-a-clinical-phase-2-study-with-rabeximod-in-covid-19-patients-301188427.html
https://www.prnewswire.com/news-releases/cyxone-files-patent-application-to-extend-exclusivity-of-rabeximod-301169999.html#:~:text=Cyxone%20files%20patent%20application%20to%20extend%20exclusivity%20of%20Rabeximod,-News%20provided%20by&text=STOCKHOLM%2C%20Nov.%2010%2C%202020,other%20territories%20in%20due%20course.